IGI Securities Limited - Investor Kit - Top News.

New York -- June 30, 2020 (PPI-OT)

Gilead to charge $2,340 for Covid-19 treatment remdesivir

Gilead Sciences has said it will charge governments $2,340 for a 5-day course of remdesivir, a drug that has been shown to shorten recovery times in...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT